» Articles » PMID: 18567755

Retinoids Modulate Expression of the Endocytic Partners Megalin, Cubilin, and Disabled-2 and Uptake of Vitamin D-binding Protein in Human Mammary Cells

Overview
Journal J Nutr
Publisher Elsevier
Date 2008 Jun 24
PMID 18567755
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The major circulating form of vitamin D, 25-hydroxycholecalciferol (25D3), circulates bound to vitamin D-binding protein (DBP). Prior to activation to 1,25-dihydroxycholecalciferol in the kidney, the 25D3-DBP complex is internalized via receptor-mediated endocytosis, which is absolutely dependent on the membrane receptors megalin and cubilin and the adaptor protein disabled-2 (Dab2). We recently reported that mammary epithelial cells (T-47D) expressing megalin, cubilin, and Dab2 rapidly internalize DBP via endocytosis, whereas cells that do not express all 3 proteins (MCF-7) do not. The objectives of this study were to characterize megalin, cubilin, and Dab2 expression and transport of DBP in human mammary epithelial cells. Using immunoblotting and real-time PCR, we found that megalin, cubilin, and Dab2 were expressed and dose dependently induced by all-trans-retinoic acid (RA) in T-47D human breast cancer cells and that RA-treated T-47D cells exhibited enhanced DBP internalization. These are the first studies to our knowledge to demonstrate that mammary epithelial cells express megalin, cubilin, and Dab2, which are enhanced during differentiation and may explain, at least in part, our finding that receptor-mediated endocytosis of DBP is upregulated in differentiated mammary epithelial cells.

Citing Articles

Epigenetic Silencing of Is Associated with Dedifferentiation and Poor Survival in Multiple Solid Tumor Types.

Rasmussen M, Tindbaek G, Nielsen M, Merrild C, Steiniche T, Pedersen J Cancers (Basel). 2023; 15(6).

PMID: 36980716 PMC: 10046670. DOI: 10.3390/cancers15061830.


Megalin and Vitamin D Metabolism-Implications in Non-Renal Tissues and Kidney Disease.

Khan S, Petkovich M, Holden R, Adams M Nutrients. 2022; 14(18).

PMID: 36145066 PMC: 9506339. DOI: 10.3390/nu14183690.


Contribution of the Low-Density Lipoprotein Receptor Family to Breast Cancer Progression.

Campion O, Al Khalifa T, Langlois B, Thevenard-Devy J, Salesse S, Savary K Front Oncol. 2020; 10:882.

PMID: 32850302 PMC: 7406569. DOI: 10.3389/fonc.2020.00882.


Imaging Cobalamin Uptake within Malignant Breast Tumors In Vivo.

Collins D Mol Imaging Biol. 2018; 21(2):356-367.

PMID: 29931431 DOI: 10.1007/s11307-018-1232-9.


Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

Saburi E, Saburi A, Ghanei M Caspian J Intern Med. 2017; 8(4):228-238.

PMID: 29201312 PMC: 5686300. DOI: 10.22088/cjim.8.4.228.


References
1.
Gallagher H, Oleinikov A, Fenske C, Newman D . The adaptor disabled-2 binds to the third psi xNPxY sequence on the cytoplasmic tail of megalin. Biochimie. 2004; 86(3):179-82. DOI: 10.1016/j.biochi.2004.03.001. View

2.
Rashid S, Moore J, Walker E, Driver P, Engel J, Edwards C . Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene. 2001; 20(15):1860-72. DOI: 10.1038/sj.onc.1204269. View

3.
Grant W . Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res. 2003; 164:371-7. DOI: 10.1007/978-3-642-55580-0_27. View

4.
Knekt P, Jarvinen R, Seppanen R, Pukkala E, Aromaa A . Intake of dairy products and the risk of breast cancer. Br J Cancer. 1996; 73(5):687-91. PMC: 2074353. DOI: 10.1038/bjc.1996.119. View

5.
Barth J, Argraves W . Cubilin and megalin: partners in lipoprotein and vitamin metabolism. Trends Cardiovasc Med. 2001; 11(1):26-31. DOI: 10.1016/s1050-1738(01)00080-9. View